Target intelligence / Profile preview

NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa pseudogene (None)

Target
None
Molecular classification
Pseudogene, Other
01

Overview

NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa pseudogene is a non-protein-coding genomic segment related in sequence to the functional NDUFB9 gene, which encodes a mitochondrial Complex I accessory subunit involved in electron transport[1][7]. This pseudogene does not produce a functional protein and has no established biological or pharmacological relevance. Pseudogenes generally arise from gene duplication or retrotransposition events and accumulate mutations that prevent their expression or function as a protein. Therefore, this gene is not considered a therapeutic target or associated with human disease. If you require information on the related functional gene NDUFB9 instead, please clarify—the NDUFB9 protein does contribute to the electron transport chain and has some clinical relevance, unlike its pseudogene[1][7].

Other names
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, pseudogeneNDUFB9 pseudogeneComplex I subunit 9 pseudogene22kDa pseudogene
02

Mechanism of action

None (drugs do not act on pseudogenes, but on their functional protein counterparts if present)

03

Biological functions

None
04

Disease associations

None
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa pseudogene (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa pseudogene (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call